Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Glycocalyx Research Institute is a biotechnology organization dedicated to the study of the endothelial glycocalyx, the protective lining of the microvascular system. The institute is best known for developing GlycoCheck, a non-invasive diagnostic platform that utilizes sublingual video microscopy and proprietary software to assess microvascular health. Their research focuses on how glycocalyx degradation contributes to major health issues, including heart disease, kidney failure, and complications from viral infections. By providing tools for early detection and monitoring, the institute aims to facilitate the development of targeted therapies to restore microvascular function.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Glycocalyx Research Institute.